Tag: Dr. Stephen Salloway
Butler Hospital, Brown University launch research to better diagnose Alzheimer’s
PROVIDENCE – Butler Hospital and Brown University have launched a new research study to find methods for early and accurate diagnosis of Alzheimer’s disease.
The...
Two R.I. hospitals involved in global trial that found effective drug...
PROVIDENCE – Scientists at two Rhode Island hospitals were part of a global clinical trial that proved a new drug can slow the decline...
Butler Hospital unveils new infusion suite for Memory and Aging Program
PROVIDENCE – Butler Hospital has unveiled a new infusion suite for its Memory and Aging Program, a space designed to provide “a contemplative or...
R.I. Alzheimer’s expert among group that released recommendations on blood tests
PROVIDENCE – A Rhode Island doctor is among a group of worldwide Alzheimer’s disease experts who released recommendations in late July on the use...
Butler psychiatry resident honored by National Institute of Mental Health
PROVIDENCE – A Butler Hospital psychiatry resident and researcher has been selected for a prestigious national honor.
Dr. Matthew David Howe is the 2022 recipient...
Salloway to step down as Butler’s Memory and Aging Program director
PROVIDENCE – Butler Hospital’s Dr. Stephen Salloway, a neurologist who has earned international recognition for his research on treatments for Alzheimer’s disease, will step...
R.I. Alzheimer’s expert among group offering guidance on groundbreaking treatment
PROVIDENCE – A Rhode Island doctor was among a group of leading Alzheimer’s disease experts who presented detailed guidance last week on the use...
Butler Hospital first to begin trials for Alzheimer’s prevention drug
PROVIDENCE – Butler Hospital has become the first site to administer a drug that is being studied worldwide by researchers looking to prevent Alzheimer’s...
Memory centers at 2 R.I. hospitals begin study of drug to...
PROVIDENCE – Two Rhode Island hospitals are recruiting participants for a study into whether a new drug can help prevent the onset of Alzheimer’s...
Alzheimer’s drug studied in R.I. heads to FDA for approval
PROVIDENCE – An investigational Alzheimer’s disease drug studied extensively in Rhode Island has been submitted to the U.S. Food and Drug Administration for approval.
The...
- Featured Event -
